Paul Tudor Jones Corcept Therapeutics Inc Transaction History

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 4,000 shares of CORT stock, worth $314,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,000

Previous 2,500 60.0%

Holding current value

$314,400

Previous $285,000 2.81%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$44.66 - $60.85 $2.37 Million - $3.24 Million	53,169 New	53,169 $2.68 Million
Q3 2023 Nov 15, 2023	BUY	$21.97 - $33.8 $549 - $844	25 Added 0.05%	51,242 $1.4 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $71,566 - $83,950	3,338 Added 6.97%	51,217 $1.14 Million
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $919,276 - $1.17 Million	47,879 New	47,879 $1.04 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $851,087 - $1 Million	34,457 New	34,457 $883,000
Q3 2020 Nov 16, 2020	SELL	$12.46 - $19.98 $964,615 - $1.55 Million	-77,417 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$11.0 - $18.26 $1.05 Million - $1.75 Million	-95,643 Reduced 55.27%	77,417 $1.3 Million
Q1 2020 May 15, 2020	BUY	$10.11 - $14.04 $137,556 - $191,028	13,606 Added 8.53%	173,060 $2.06 Million
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $191,850 - $269,799	-15,908 Reduced 9.07%	159,454 $1.93 Million
Q3 2019 Nov 14, 2019	SELL	$10.41 - $14.66 $644,420 - $907,512	-61,904 Reduced 26.09%	175,362 $2.48 Million
Q2 2019 Aug 14, 2019	BUY	$9.78 - $12.76 $213,262 - $278,244	21,806 Added 10.12%	237,266 $2.65 Million
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $532,171 - $833,541	53,058 Added 32.67%	215,460 $2.53 Million
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $1.53 Million - $2.34 Million	135,902 Added 512.84%	162,402 $2.17 Million
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $325,155 - $414,725	26,500 New	26,500 $372,000
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $158,569 - $204,067	-10,364 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $151,210 - $264,282	10,364 New	10,364 $170,000
Q4 2017 Feb 14, 2018	SELL	$15.77 - $20.72 $547,755 - $719,688	-34,734 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $427,228 - $670,366	34,734	34,734 $670,000

Others Institutions Holding CORT

# of Institutions

471

Shares Held

83.5M

Call Options Held

489K

Put Options Held

1.02M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $8.42B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account